Results
Type
Qualifications

Methylphenidate | compare suppliers & send inquiries for free

Here you will find a list of producers, manufacturers and traders of Methylphenidate. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
This product is listed at the international narcotic list. The purchase and handling are strictly ruled by national and international laws. Pharmaoffer will validate buyers and suppliers before an order can be settled.

Dear user,

Your company must be approved before narcotic products will be shown. So please register your company here.

Already have an account? The verification can take some time, if you feel like it's taking too long, please let us know.


Kind regards,
Team Pharmaoffer

 

Looking for Methylphenidate 113-45-1?

API | Excipient name:
Methylphenidate 
Synonyms:
Daytrana, Methyl phenidylacetate, Methylphenidan, Methylphenidate, Methylphenidatum, Metilfenidato, MPH, Methylphenidati, Methylphenidate hydrochloride, Methylfenidaat  
Cas Number:
113-45-1 
DrugBank number:
DB00422 
Unique Ingredient Identifier:
207ZZ9QZ49

About Methylphenidate

What can you use it for? Methylphenidate is a central nervous system stimulant used most commonly in the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) and for narcolepsy. Also known as the marketed products Ritalin, Concerta, or Biphentin, methylphenidate is used with other treatment modalities (psychological, educational, cognitive behaviour therapy, etc) to improve the following group of developmentally inappropriate symptoms associated with ADHD: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. Long-acting formulations of psychostimulants such as methylphenidate, Dextroamphetamine, and Lisdexamfetamine are considered the most effective and widely used treatment for ADHD, and are considered first-line options for children, adolescents, and adults as recommended by CADDRA (Canadian ADHD Resource Alliance).2 CADDRA recommends the use of methylphenidate due to long term studies, of over twenty years in duration, which show methylphenidate is safe and effective.

While its exact mechanism is unclear, methylphenidate (MPH) has been shown to act as a norepinephrine and dopamine reuptake inhibitor (NDRI), thereby increasing the presence of these neurotransmitters in the extraneuronal space and prolonging their action.

You can ask the supplier for more technical information about the product.